Inactive Instrument

Qiagen Share Price Nasdaq

Equities

NL0012169213

Biotechnology & Medical Research

Sales 2024 * 2.01B 161B Sales 2025 * 2.14B 171B Capitalization 9.22B 736B
Net income 2024 * 398M 31.78B Net income 2025 * 442M 35.3B EV / Sales 2024 * 4.74 x
Net Debt 2024 * 300M 23.98B Net cash position 2025 * 280M 22.37B EV / Sales 2025 * 4.17 x
P/E ratio 2024 *
23.5 x
P/E ratio 2025 *
21 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.45%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 31/01/15
Founder 69 28/04/96
Director of Finance/CFO 56 31/12/98
Members of the board TitleAgeSince
Director/Board Member 74 31/05/11
Founder 69 28/04/96
Chairman 66 25/06/13
More insiders
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
More about the company